Relay Therapeutics Inc (RLAY)
6.635
+0.12
(+1.92%)
USD |
NASDAQ |
May 17, 16:00
6.635
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Total Assets (Quarterly): 841.44M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 841.44M |
| December 31, 2023 | 843.98M |
| September 30, 2023 | 906.96M |
| June 30, 2023 | 962.02M |
| March 31, 2023 | 1.038B |
| December 31, 2022 | 1.100B |
| September 30, 2022 | 1.169B |
| June 30, 2022 | 889.42M |
| March 31, 2022 | 949.88M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.008B |
| September 30, 2021 | 671.62M |
| June 30, 2021 | 714.40M |
| March 31, 2021 | 771.35M |
| December 31, 2020 | 799.83M |
| September 30, 2020 | 751.68M |
| June 30, 2020 | 348.04M |
| March 31, 2020 | 370.27M |
| December 31, 2019 | 393.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
348.04M
Minimum
Jun 2020
1.169B
Maximum
Sep 2022
807.14M
Average
842.71M
Median
Total Assets (Quarterly) Benchmarks
| Olema Pharmaceuticals inc | 263.69M |
| Moderna Inc | 16.73B |
| Exelixis Inc | 2.804B |
| Geron Corp | 482.07M |
| Regeneron Pharmaceuticals Inc | 34.37B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 95.68M |
| Shareholders Equity (Quarterly) | 745.76M |
| Current Ratio | 20.73 |